Form 8-K - Current report:
SEC Accession No. 0001274737-23-000004
Filing Date
2023-01-23
Accepted
2023-01-23 09:00:18
Documents
14
Period of Report
2023-01-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20230123.htm   iXBRL 8-K 40497
2 EX-3.1 exhibit-exagenxamendmentto.htm EX-3.1 6753
3 EX-99.1 xgnchairtransitionpressrel.htm EX-99.1 11239
  Complete submission text file 0001274737-23-000004.txt   210936

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20230123.xsd EX-101.SCH 1896
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20230123_lab.xml EX-101.LAB 25832
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20230123_pre.xml EX-101.PRE 13574
8 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20230123_htm.xml XML 12282
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 23542642
SIC: 8071 Services-Medical Laboratories